Autologous mesenchymal stem cell transplantation for spinal fusion: 10 years follow-up of a phase I/II clinical trial

Autologous mesenchymal stem cell transplantation for spinal fusion: 10 years follow-up of a phase I/II clinical trial

Abstract Posterolateral spinal fusion is the standard surgical approach for patients with degenerative disc disease. In our previously published article, we reported a 5-years follow-up of a phase I/II clinical trial in patients undergoing spinal fusion with autologous mesenchymal stem cells (MSCs)...

Full description

Bibliographic Details
Main Authors: Victoria Gomez-Ruiz, Juan F. Blanco, Eva M. Villarón, Helena Fidalgo, Miriam López-Parra, Fermín Sánchez-Guijo
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Stem Cell Research & Therapy
Subjects:
Mesenchymal stem cells
Spinal fusion
Bone graft
Intervertebral disc degeneration
Cell transplantation
Online Access:https://doi.org/10.1186/s13287-023-03298-4

Internet

https://doi.org/10.1186/s13287-023-03298-4

Similar Items